Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Phase I/II Study to Evaluate the Efficacy and Safety of a Combination Chemotherapy

This study has been completed.
Sponsor:
Collaborators:
Millennium Pharmaceuticals, Inc.
Genentech, Inc.
Information provided by (Responsible Party):
William Walsh, University of Massachusetts, Worcester
ClinicalTrials.gov Identifier:
NCT00424840
First received: January 18, 2007
Last updated: November 18, 2014
Last verified: November 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2014
  Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)